Отзывы

In Solodyn, where the settlement and business agreements at issue allegedly totalled over US 63 million in payments, 34 the court held that the plaintiffs had presented sufficient evidence to support their at risk launch theory that the generic defendant would have launched its product prior to the conclusion of the patent litigation absent the allegedly anticompetitive settlement nolvadex